Diabetes Shouldn’t Define You
Diabetes impacts the lives of millions of people each year, but it shouldn’t define who you are. If you’ve been diagnosed with type 2 diabetes and are overweight you may already know how important it is to monitor your blood sugar, eat healthy and be active.
Physicians in your area are studying an investigational medication compared to an already approved medication in the treatment of type 2 diabetes.
Eligible participants are overweight and have type 2 diabetes. To qualify you must also be taking Metformin for the treatment of diabetes for at least 3 months. Patients receiving treatment with other diabetes medications within the past 3 months will not be allowed.
If you qualify, you will receive all study-related care, including physical exams, lab services, and study medications. During participation you will remain on a dose of Metformin.
For more information please call,
Diablo Clinical Research at 925-930-7267
| Condition | Weight Loss |
|---|---|
| Clinical Study Identifier | TX134499 |
| Last Modified on | 21 April 2022 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.